Skip to main content
Log in

Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit

  • Review Article
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dodrill FD (1958) The effects of total body perfusion on the lungs. In: Allen JG (ed) Extracorporeal circulation. Springfield, Thomas, p 327

    Google Scholar 

  2. Allardyce DB, Yoshida SH, Ashmore PG (1966) The importance of microembolism in the pathogenesis of organ dysfunction caused by prolonged use of the pump-oxygenator. J Thorac Cardiovasc Surg 52:706

    Google Scholar 

  3. Kirklin JW (1980) Open heart surgery at the Mayo Clinic; the 25the Anniversary. Mayo Clin Proc 55:339

    Google Scholar 

  4. Kirklin JK, Blackstone EH, Kirklin JW, McKay R, Pacifico AD (1981) Intracardiac surgery in infants under three months. Incremental risk factors for hospital mortality. Am J Cardiol 48:500

    Google Scholar 

  5. Downs JJ, Nicodemus HF, Pierce WS, Waldhausen JA (1970) Acute respiratory failure in infants following cardiovascular surgery. J Thorac Cardiovasc Surg 59:21

    Google Scholar 

  6. Westaby S (1983) Complement and the damaging effects of cardiopulmonary bypass. Thorax 38:321

    Google Scholar 

  7. Bachmann F, McKenna R, Cole ER, Najafi H (1975) The haemostatic mechanism after open heart surgery. I. Studies in plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 70:76

    Google Scholar 

  8. McKenna R, Bachmann F, Whittaker B, Gilson JR, Weinberg M (1975) The haemostatic mechanism after open heart surgery. II. Frequency of abnormal platelet function during and after extracorporeal circulation. J Thorac Cardiovasc Surg 70:298

    Google Scholar 

  9. Abel RM, Buckley MJ, Austen WG, Barnett GO, Beck CH, Fischer JE (1976) Aetiology, incidence and prognosis of renal failure following cardiac operations. J Thorac Cardiovasc Surg 71:323

    Google Scholar 

  10. Abel RM, Wick J, Beck CH, Buckley MJ, Austen WG (1974) Renal failure following open heart operations. Arch Surg 108:175

    Google Scholar 

  11. Lillehei CW, Cohen M, Warden HE, Zeigler NR, Varco RL (1955) The results of direct vision closure of ventricular septal defects in eight patients by means of controlled cross circulation. Surg Gynecol Obstet 10:447

    Google Scholar 

  12. Reed CC, Ramagnoli I, Taylor DE, Clark DF (1974) Particulate matter in bubble oxygenators. J Thorac Cardiovasc Surg 68:971

    Google Scholar 

  13. Lee WH, Krumbhaar D, Fomkalsrud EW, Schjeide OA, Maloney JV (1961) Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations. Surgery 50:29

    Google Scholar 

  14. Livelli FD, Johnson RA, McEnany MT (1978) Unexplained inhospital fever following cardiac surgery. Circulation 968

  15. Anderson NB, Ghia J (1970) Pulmonary function, cardiac status and post operative course in relation to cardiopulmonary bypass. J Thorac Cardiovasc Surg 59:474

    Google Scholar 

  16. Kouchoukos NT, Karp RB (1981) Functional disturbances following extracorporeal circulatory support in cardiac surgery. In: Inoescu MI (ed) Techniques in extracorporeal circulation. Butterworths, London, p 297

    Google Scholar 

  17. Snashall PD, Weidner WJ, Staub NC (1977) Extravascular lung water after extracellular fluid volume expansion in dogs. J Appl Physiol 42:624

    Google Scholar 

  18. Boldt J, Bormann B, Kling D, Hoge R, Hempelmann G (1985) The influence of cardiopulmonary bypass on lung water content. In: Hagl S, Klovekorn WP, Mayr N, Sebening F (eds) Thirty years of extracorporeal circulation. Deutsches Herzzentrum München, p 127

  19. Royston D, Catley DM, Higgenbottam T, Wallwork J, Minty BD (1986) Changes in alveolar capillary barrier function associated with cardiopulmonary bypass. Ann Thorac Surg

  20. Wilson JW (1974) The pulmonary cellular and subcellular alterations of extracorporeal circulation. Surg Clin North Am 54:1204

    Google Scholar 

  21. Ratliff NB, Young WG, Hackel DB, Mikat E, Wilson JW (1973) Pulmonary injury secondary to extracorporeal circulation. J Thorac Cardiovasc Surg 65:425

    Google Scholar 

  22. Connell RS, Page US, Barley TD, Bigelow JC, Webb MC (1973) The effect on pulmonary ultra structure of Dacron wool filtration during cardiopulmonary bypass. Ann Thorac Surg 15:217

    Google Scholar 

  23. Morgan TE (1971) Pulmonary surfactant. N Engl J Med 284:1185

    Google Scholar 

  24. Barratt-Boyes BG, Simpson M, Neutze JM (1971) Intracardiac surgery in neonates and infants using deep hypothermia with surface cooling and limited cardiopulmonary bypass. Circulation 43 and 44 (Suppl II):25

    Google Scholar 

  25. Ruddy S, Gigli I, Austen KF (1972) The complement system of man. N Engl J Med 287:489

    Google Scholar 

  26. Parker DJ, Cantrell JW, Karp RB, Stroud RM, Digerness SB (1972) Changes in serum complement and immunoglobulins following cardiopulmonary bypass. Surgery 71:824

    Google Scholar 

  27. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacobs HS (1977) Haemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyser cellophane membranes. J Clin Invest 59:879

    Google Scholar 

  28. Hohn DC, Meyers AJ, Gherini ST, Beckman A, Markison RE, Churg AM (1980) Production of acute pulmonary injury by leucocytes and activated complement. Surgery 88:48

    Google Scholar 

  29. Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, Ozalins M, Nicoloff DM, Lillehei RC, Craddock PR, Jacobs HS (1981) Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 81:370

    Google Scholar 

  30. Fountain SW, Martin BA, Musclow CE, Cooper JD (1980) Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits. Circ Res 46:175

    Google Scholar 

  31. Hugli TE, Chenoweth DE (1981) Biologically active peptides of complement. Techniques and significance of C3a and C5a measurements. In: Nakamura RM, Dito WR, Tucker ES (eds) Future perspectives in clinical laboratory immunoassays. Alan R Liss New York, p 443

    Google Scholar 

  32. Chenoweth DE, Cooper SW, Hugli TE, Stewart R, Blackstone EH, Kirklin JW (1981) Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 304:497

    Google Scholar 

  33. Kirklin JW, Westaby S, Blackstone EH, Kirklin JW, Pacifico AD, Chenoweth DE (1983) Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86:845

    Google Scholar 

  34. Van Oeveren W, Kazatchkine MD, Descamps-Latscha B, Maillet F, Fischer E, Carpertier A, Wildevuur CRH (1985) Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 89:888

    Google Scholar 

  35. Van Oeveren W, Yan-Ji J, Eysman L, Jansen D, Wildevuur CRH (1966) Corticosteroids inhibit material-independent complement activation during cardiopulmonary bypass. Submitted to J Thorac Cardiovasc Surg

  36. Quiroga MM, Miyagishima R, Haendschen LC, Glovsky M, Martin BA, Hogg JC (1985) The effect of body temperature on leucocyte kinetic during cardiopulmonary bypass. J Thorac Cardiovasc Surg 90:91

    Google Scholar 

  37. Royston D, Fleming JS, Desai JB, Westaby S, Taylor KM (1986) Increased production of peroxidation products associated with cardiac surgery. Evidence for free radical generation. J Thorac Cardiovasc Surg 91:759

    Google Scholar 

  38. Westaby S, Fleming JS, Royston D, Taylor KM (1984) Evidence for generations of free radical species during cardiopulmonary bypass in man. In: Hagl S, Klovekorn W, Mayr N, Sebening F (eds) Thirty years of extracorporeal circulation. Deutsches Herzzentrum München, p 389

  39. Replogle RL, Gazzaniga AB, Gross RE (1966) Use of corticosteroids during cardiopulmonary bypass. Possible lysosomal stabilisation. Circulation 33 and 34 [Suppl I]:86

    Google Scholar 

  40. Gnanadurai TV, Branthwaite MA, Colbeck JF, Wellman E (1978) Lysosomal enzyme release from the lungs after cardiopulmonary bypass. Anaesthesia 33:227

    Google Scholar 

  41. Bolanowski PJ, Bauer J, Machiedo G, Neville WE (1977) Prostaglandin influence on pulmonary intravascular leucocytic aggregation during cardiopulmonary bypass. J Thorac Cardiovasc Surg 73:221

    Google Scholar 

  42. Havel M, Duma S, Graninger W, Moritz A, Fasol R, Zilla P (1984) Release of granulocyte elastase during cardiopulmonary bypass. In: Interactions of cells with natural and foreign surfaces. Abstracts of symposium. Institute of Basic Medical Sciences, Royal College of Surgeons, p 42

  43. Cochrane CG, Spragg RG, Devak SD, Cohen AB, McGuire WW (1983) The presence of neutrophil elastase and evidence of oxidant activity in bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 127:525

    Google Scholar 

  44. Zaslow MC, Clark RA, Stone PJ, Calore JD, Snider GL, Franzblau C (1983) Human neutrophil elastase does not bind to alpha1-protease inhibitors that has been exposed to activated human neutrophils. Am Rev Respir Dis 128:434

    Google Scholar 

  45. MacGreger R, Spanuolo P, Lefner A (1974) Inhibition of granulocyte adherence by ethanol, prednisolone and aspirin measured with an assay system. N Engl J Med 291:642

    Google Scholar 

  46. Sibbald WJ, Anderson RR, Reid B, Holliday RL, Driedger AA (1981) Alveolar-capillary permeability in human septic adult respiratory distress syndrome. Chest 79:133

    Google Scholar 

  47. Goldstein IM, Roos D, Weissman G, Kaplan HB (1976) Influence of corticosteroids on human polymorphonuclear leucocyte function in vitro, reduction of lysosomal enzyme release and superoxide production. Inflammation 1:305

    Google Scholar 

  48. Sladen A (1976) Methylprednisolone — pharmacological doses in shock lung syndrome. J Thorac Cardiovasc Surg 71:800

    Google Scholar 

  49. Fritz H, Winderer G (1983) Biochemistry and applications of aprotinin, the Kallikretin inhibitor from bovine agents. Arzneimittelforsch 33:479

    Google Scholar 

  50. McCord JM, Wong K, Stokes SH, Retrone WF, English D (1980) Superoxide and inflammation: a mechanism for the anti-oxidant activity of superoxide dismutase. Acta Physiol Scand [Suppl] 429:25

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Westaby, S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 13, 89–95 (1987). https://doi.org/10.1007/BF00254791

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00254791

Keywords

Navigation